Immunohistochemical analyses showed that IBC induced a substantial increase in RIP3 and MLKL and activated the RIP1-RIP3-MLKL pathway in the MDA-MB-231 derived tumor (Figure 10E,F). The gene discussed is MLKL; the disease is neoplasm.